A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Pharmacokinetics of Single Ascending and Multiple Doses of Prosetin in Healthy Volunteers
Study Purpose:
This trial is a Phase 1a/1b, randomized, double-blind, placebo-controlled study designed to assess the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of prosetin administered to healthy adult subjects.
Disease:
Healthy Volunteer, Healthy Volunteer with a Family History of ALSStudy Type:
Interventional TrialStudy Category:
Drug TrialStudy Status:
EnrollingPhase:
Phase IStudy Chair(s)/Principal Investigator(s):
Clinicaltrials.gov ID (11 digit #):
NCT05279755Neals Affiliated?
NoCoordinating Center Contact Information
ProJenX Clinical Trials / .(JavaScript must be enabled to view this email address) / 917-423-6476
.(JavaScript must be enabled to view this email address) United States